Literature DB >> 8877075

Left ventricular diastolic function during adrenergic stress in essential hypertension: acute and chronic effects of ACE inhibition.

G Covi1, I Sheiban, G Gelmini, G Arcaro, S Tonni, A Bolner, G Piemonte, A Lechi.   

Abstract

We studied the changes in left ventricular (LV) diastolic function induced by angiotensin-converting enzyme (ACE) inhibition at rest and during adrenergic stimulation and their relation to blood pressure (BP) variations to determine whether reductions in the renin-angiotensin system may improve diastolic function irrespective of BP reduction. Echocardiographic indices of systolic and diastolic function, plasma catecholamines as estimated by high-pressure liquid chromatography, and BP variations (Dynamap) were determined at rest and during the cold pressor test (CPT) before and 6 hours and 20 days after ACE inhibition (lisinopril), 20 mg/day by mouth in 10 subjects with uncomplicated essential hypertension. Blood Pressure was significantly reduced after both 6 hours and 20 days of therapy. The cold pressor test induced similar increases in BP in both basal conditions and after acute and chronic treatment. Catecholamine levels were unchanged by the therapy. Systolic function, evaluated by fractional shortening, ejection fraction, and systolic dV/dt, was normal and unchanged during CPT and after treatment. Diastolic function, assessed by volume curve analysis, showed a reduced percentage contribution of rapid filling to total diastolic filling, an increase in the contribution of the atrial systole, and an increase in the isovolumetric relaxation time. During CPT these parameters deteriorated further in response to increased afterload. Lisinopril therapy induced significant increases in end-diastolic volume (p < 0.005) with a progressive increase in the rapid filling dV/dt (p < 0.005 at rest; p < 0.001 during CPT) and a reduction in isovolumetric relaxation (p < 0.0001 at rest and p < 0.01 during CPT). The correlation between systolic BP (afterload) and the rapid filling dV/dt, both at rest and during CPT, was modified by treatment with the ACE inhibitor, with significantly higher rapid filling dV/dt values, and with the pressure loads equal (reduction of the slope and rightward shift of the correlation line). The improvement in diastolic function achieved by ACE inhibition at rest and during CPT appears unrelated to plasma catecholamines and only partly ascribable to the reduced pressure load. The tissue angiotensin II reduction might by itself improve the myocardial response to the pressure load and adrenergic stimulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877075     DOI: 10.1007/bf02627956

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  31 in total

1.  CORONARY AND MYOCARDIAL ACTIONS OF ANGIOTENSIN.

Authors:  N O FOWLER; J C HOLMES
Journal:  Circ Res       Date:  1964-03       Impact factor: 17.367

2.  Angiotensin II increases spontaneous contractile frequency and stimulates calcium current in cultured neonatal rat heart myocytes: insights into the underlying biochemical mechanisms.

Authors:  I S Allen; N M Cohen; R S Dhallan; S T Gaa; W J Lederer; T B Rogers
Journal:  Circ Res       Date:  1988-03       Impact factor: 17.367

3.  Effect of regression of left ventricular hypertrophy following sotalol therapy on diastolic function in hypertensive patients.

Authors:  M M Ibrahim; S S Zaghloul; S M Helmi
Journal:  J Hypertens Suppl       Date:  1987-12

4.  Effects of sympathetic nerve stimulation are attenuated by the converting enzyme inhibitor Hoe 498 in isolated rabbit hearts.

Authors:  J Z Xiang; B A Schölkens; D Ganten; T Unger
Journal:  Clin Exp Hypertens A       Date:  1984

5.  Triple control of relaxation: implications in cardiac disease.

Authors:  D L Brutsaert; F E Rademakers; S U Sys
Journal:  Circulation       Date:  1984-01       Impact factor: 29.690

6.  Diastolic function of the heart in untreated primary hypertension.

Authors:  M Hartford; J Wikstrand; I Wallentin; S Ljungman; L Wilhelmsen; G Berglund
Journal:  Hypertension       Date:  1984 May-Jun       Impact factor: 10.190

7.  Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.

Authors:  H Schunkert; B Jackson; S S Tang; F J Schoen; J F Smits; C S Apstein; B H Lorell
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

8.  Cardiac renin-angiotensin system. Molecular and functional aspects.

Authors:  V J Dzau
Journal:  Am J Med       Date:  1988-03-11       Impact factor: 4.965

9.  Echocardiographic assessment by computer-assisted analysis of diastolic left ventricular function and hypertrophy in borderline or mild systemic hypertension.

Authors:  V Papademetriou; J S Gottdiener; R D Fletcher; E D Freis
Journal:  Am J Cardiol       Date:  1985-09-15       Impact factor: 2.778

Review 10.  A review of the renin-angiotensin system in the normal heart.

Authors:  A Mebazaa; B Chevalier; J J Mercadier; E Echter; L Rappaport; B Swynghedauw
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

View more
  2 in total

Review 1.  Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.

Authors:  H D Langtry; A Markham
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

2.  Deleterious Effects of Cold Air Inhalation on Coronary Physiological Indices in Patients With Obstructive Coronary Artery Disease.

Authors:  Rupert P Williams; Kaleab N Asrress; Matthew Lumley; Satpal Arri; Tiffany Patterson; Howard Ellis; Vasiliki Manou-Stathopoulou; Catherine Macfarlane; Shruthi Chandran; Kostantinos Moschonas; Pippa Oakeshott; Timothy Lockie; Amedeo Chiribiri; Brian Clapp; Divaka Perera; Sven Plein; Michael S Marber; Simon R Redwood
Journal:  J Am Heart Assoc       Date:  2018-07-17       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.